Calendar

Week of Mar 2, 2026

Mar 5, 2026grant179d agoUNIVERSITY OF WYOMING — Cell Fusion and Gene Expression in the C. elegans Epidermis

GM grant. $123,687. PI: Owen Funk

Mar 5, 2026grant179d agoNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC — Longitudinal Pet Imaging Of Antipsychotic Binding To The Dopamine-3 Receptor ...

MH grant. $843,322. PI: Ragy Ramsis Girgis

full page →nih reporter ↗

Mar 5, 2026grant179d agoUNIVERSITY OF PENNSYLVANIA — Training Leaders to Improve Outcomes in Older Adults Using Advanced MethodsUniversity of Pennsylvania

AG grant. $214,223. PI: Robert Edward Burke

full page →nih reporter ↗

Mar 5, 2026grant179d agoUNIVERSITY OF COLORADO — The Menses Study: Menstrual blood as a novel target-tissue biomatrix for chem...

OD grant. $434,110. PI: Jenni Shearston

full page →nih reporter ↗

Mar 5, 2026grant179d agoNEW YORK UNIVERSITY — Neural circuit mechanisms of dynamic learning ratesNew York University

MH grant. $710,563. PI: Christine M Constantinople

full page →nih reporter ↗

Mar 5, 2026grant179d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Mapping the Mechanome: A Systems-level Understanding of Mechanical Mediators ...University of California Los Angeles

GM grant. $433,125. PI: Amy C Rowat

full page →nih reporter ↗

Mar 5, 2026grant179d agoBOSTON UNIVERSITY (CHARLES RIVER CAMPUS) — Advancing targeted delivery of intracellular protein therapeutics

GM grant. $449,625. PI: Samagya Banskota

full page →nih reporter ↗

Mar 5, 2026grant179d agoUNIVERSITY OF IOWA — Role of Notch Pathway in the Pathogenesis of Chronic PancreatitisUniversity of Iowa

DK grant. $655,482. PI: VIKAS DUDEJA

full page →nih reporter ↗

Mar 5, 2026grant179d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Controlling epilepsy symptoms with precisely timed inhibition and circuit edi...

NS grant. $75,880. PI: Christopher David Adam

full page →nih reporter ↗

Mar 5, 2026grant179d agoUT SOUTHWESTERN MEDICAL CENTER — The roles of Rett Syndrome protein MECP2 at gene regulatory elements

MH grant. $641,828. PI: Hume Akahori Stroud

full page →nih reporter ↗

Mar 5, 2026grant179d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Loneliness and inflammatory markers as biopsychosocial pathways to AD/ADRD: A...

AG grant. $121,239. PI: Mara Getz Sheftel

full page →nih reporter ↗

Mar 5, 2026grant179d agoCINCINNATI CHILDRENS HOSP MED CTR — Impact of Circadian Misalignment for Adolescents with ADHD: Observational and...

MH grant. $820,196. PI: Stephen P Becker

full page →nih reporter ↗

Mar 5, 2026grant179d agoUNIVERSITY OF IOWA — Investigating single cell transcriptomics and epigenetic regulation to enable...University of Iowa

MH grant. $779,797. PI: Rainbo Hultman

full page →nih reporter ↗

Mar 5, 2026grant179d agoHENRY M. JACKSON FDN FOR THE ADV MIL/MED — Neural Plasticity and Myelin Dynamics after Amputation

NS grant. $555,265. PI: Emily Rose Petrus

full page →nih reporter ↗

Mar 5, 2026grant179d agoPUBLIC HEALTH FOUNDATION ENTERPRISES — PrEP Blueprint: Evaluating implementation of a PrEP Choice Blueprint on PrEP ...

MH grant. $659,242. PI: Hyman Scott

full page →nih reporter ↗

Mar 5, 2026grant179d agoSTANFORD UNIVERSITY — The role of expected informativity on linguistic and memory encodingStanford University

DC grant. $124,686. PI: Eleonora Judith Beier

full page →nih reporter ↗

Mar 5, 2026grant179d agoEMORY UNIVERSITY — A Foot in Each World: Bridging the Divide Between Clinical Research and the M...Emory University

MH grant. $156,500. PI: Santiago Jose Arconada Alvarez

full page →nih reporter ↗

Mar 5, 2026grant179d agoBRIGHAM AND WOMEN'S HOSPITAL — Cellular Therapy for Sepsis and Lung InjuryBrigham and Women's Hospital

GM grant. $445,983. PI: Mark A PERRELLA

full page →nih reporter ↗

Mar 5, 2026grant179d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Mechanisms that regulate cellular responses to phosphate

GM grant. $429,000. PI: Lauren Elizabeth Surface

full page →nih reporter ↗

Mar 5, 2026grant179d agoPENNSYLVANIA STATE UNIVERSITY, THE — Investigating brain-body allostasis via longitudinal in vivo imaging

GM grant. $407,603. PI: Grayson Oren Sipe

full page →nih reporter ↗

Mar 5, 2026grant179d agoUNIVERSITY OF MARYLAND BALTIMORE — SGLT2 - Novel Molecular Mechanism of AQP4 Regulation

NS grant. $602,065. PI: J. Marc Simard

full page →nih reporter ↗

Mar 6, 2026approval178d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS

full page →risankizumab →fda approvals ↗

Mar 6, 2026approval178d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION

full page →risankizumab →fda approvals ↗

Mar 6, 2026approval178d agoQUDEXY XR (TOPIRAMATE) — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval178d agoPYLARIFY TRUVU (PIFLUFOLASTAT F-18) — FDA approval

Sponsor: APHELION. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Mar 6, 2026approval178d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

full page →Restasis →fda approvals ↗

Mar 6, 2026approval178d agoQSYMIA (PHENTERMINE HYDROCHLORIDE) — FDA approval(phentermine hydrochloride + topiramate) ER

Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →(phentermine hydrochloride + topiramate) ER →fda approvals ↗

Mar 6, 2026approval178d agoTOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval178d agoXELJANZ XR (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

Sponsor: PFIZER. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Mar 6, 2026approval178d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvalBiocon Pharma Ltd

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval178d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗

Mar 6, 2026approval178d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗

Mar 6, 2026approval178d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval178d agoSIPONIMOD — FDA approvalSIPONIMOD

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →SIPONIMOD →fda approvals ↗

Mar 6, 2026approval178d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Mar 6, 2026approval178d agoSOTYKTU (DEUCRAVACITINIB) — FDA approvalBristol-Myers Squibb Co

Sponsor: BRISTOL. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval178d agoTROKENDI XR (TOPIRAMATE) — FDA approvalSUPERNUS PHARMACEUTICALS, INC.

Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval178d agoNICARDIPINE HYDROCHLORIDE — FDA approvalNICARDIPINE HYDROCHLORIDE

Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

full page →NICARDIPINE HYDROCHLORIDE →fda approvals ↗

Mar 6, 2026approval178d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: PRINSTON INC. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

Mar 6, 2026approval178d agoEVEROLIMUS — FDA approvalEVEROLIMUS

Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

full page →EVEROLIMUS →fda approvals ↗

Mar 6, 2026approval178d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION

full page →Restasis →fda approvals ↗

Mar 6, 2026approval178d agoEPRONTIA (TOPIRAMATE) — FDA approvaltopiramate ER

Sponsor: AZURITY. Form: SOLUTION. Route: ORAL

full page →topiramate ER →fda approvals ↗

Mar 6, 2026approval178d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL

full page →Restasis →fda approvals ↗

Mar 6, 2026approval178d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

Sponsor: PFIZER. Form: SOLUTION. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Mar 6, 2026grant178d agoUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA — Vocal Development and Social Communication Outcomes of Children with an Older...

DC grant. $216,612. PI: Lisa M Hamrick

full page →nih reporter ↗

Mar 6, 2026grant178d agoGORDON RESEARCH CONFERENCES — 2026 Neurobiology of Cognition Gordon Research Conference and Gordon Research...

NS grant. $15,000. PI: Theresa Marie Desrochers

full page →nih reporter ↗

Mar 6, 2026grant178d agoBRIGHAM AND WOMEN'S HOSPITAL — Identifying and Restoring Mechanisms Driving DRPLA-Associated Epilepsy.Brigham and Women's Hospital

NS grant. $479,687. PI: Melissa Leigh Barker-Haliski

full page →nih reporter ↗

Mar 6, 2026grant178d agoUNIVERSITY OF MINNESOTA — A Biologically Based Approach to Prevent Obesity in Older Adolescents and You...University of Minnesota

DK grant. $759,944. PI: Aaron S Kelly

full page →nih reporter ↗

Mar 6, 2026grant178d agoJOHNS HOPKINS UNIVERSITY — MRI-guided focused ultrasound to enhance ME3BP7 delivery as a novel therapy f...Johns Hopkins University

NS grant. $214,101. PI: Jordina Rincon Torroella

full page →nih reporter ↗

Mar 6, 2026grant178d agoUNIVERSITY OF CINCINNATI — Proteomics and Cognitive Decline Following Intracerebral Hemorrhage

NS grant. $654,628. PI: Russell Patrick Sawyer

full page →nih reporter ↗

← prev

page 444 of 475

Week of Mar 2, 2026